MetaADEDB 2.0 @ LMMD
Valproic Acid
(MSRILKIQRXUYCT-UHFFFAOYSA-M)
Structure
SMILES
CCCC(C(=O)O)CCC.CCCC(C(=O)[O-])CCC.[Na+]
Molecular Formula:
C16H31NaO4
Molecular Weight:
310.405
Log P:
3.2401
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
77.43
CAS Number(s):
76584-70-8
Synonym(s)
1.
Valproic Acid
2.
Dipropyl Acetate
3.
Divalproex
4.
Sodium Valproate
5.
2-Propylpentanoic Acid
6.
Calcium Valproate
7.
Convulsofin
8.
Depakene
9.
Depakine
10.
Depakote
11.
Divalproex Sodium
12.
Ergenyl
13.
Magnesium Valproate
14.
Propylisopropylacetic Acid
15.
Semisodium Valproate
16.
Valproate
17.
Valproate Calcium
18.
Valproate Sodium
19.
Valproic Acid, Sodium Salt (2:1)
20.
Vupral
21.
2 Propylpentanoic Acid
External Link(s)
MeSHD014635
PubChem Compound23663956
22227467
ChEBI4667
CHEMBLCHEMBL2105613
KEGGdr:D00304
Therapeutic Target DatabaseD03LGY
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1PainFAERS: 696US FAERS
2Emotional distressFAERS: 622US FAERS
3DeformityFAERS: 595US FAERS
4AnhedoniaFAERS: 593US FAERS
5Physical disabilityFAERS: 577US FAERS
6Spina BifidaFAERS: 400US FAERS
7TensionFAERS: 311US FAERS
8AnxietyFAERS: 288
Canada Vigilance: 2
Canada Vigilance
US FAERS
9Impaired work abilityFAERS: 227US FAERS
10AlopeciaFAERS: 205
Canada Vigilance: 2
Canada Vigilance
US FAERS
11Product substitution issueFAERS: 198
Canada Vigilance: 9
Canada Vigilance
US FAERS
12Life expectancy shortenedFAERS: 196US FAERS
13Activities of daily living impairedFAERS: 190US FAERS
14Unevaluable eventFAERS: 183US FAERS
15Drug exposure during pregnancyFAERS: 178US FAERS
16TremorFAERS: 165
Canada Vigilance: 1
Canada Vigilance
US FAERS
17Drug ineffectiveFAERS: 157
Canada Vigilance: 13
Canada Vigilance
US FAERS
18Economic problemFAERS: 154US FAERS
19Medication residueFAERS: 137US FAERS
20Ammonia increasedFAERS: 128
Canada Vigilance: 5
Canada Vigilance
US FAERS
21SomnolenceFAERS: 110
Canada Vigilance: 6
Canada Vigilance
US FAERS
22Quality of life decreasedFAERS: 96US FAERS
23NauseaFAERS: 91
Canada Vigilance: 7
Canada Vigilance
US FAERS
24VomitingFAERS: 89
Canada Vigilance: 6
Canada Vigilance
US FAERS
25Maternal exposure during pregnancyFAERS: 85US FAERS
26Feeling abnormalFAERS: 84US FAERS
27Drug level decreasedFAERS: 81
Canada Vigilance: 6
Canada Vigilance
US FAERS
28PancreatitisFAERS: 79
Canada Vigilance: 4
Canada Vigilance
US FAERS
29Mental impairmentFAERS: 78
Canada Vigilance: 1
Canada Vigilance
US FAERS
30HeadacheFAERS: 77
Canada Vigilance: 5
Canada Vigilance
US FAERS
31DizzinessFAERS: 74
Canada Vigilance: 2
Canada Vigilance
US FAERS
32FatigueFAERS: 74
Canada Vigilance: 2
Canada Vigilance
US FAERS
33ThrombocytopeniaFAERS: 71
Canada Vigilance: 9
Canada Vigilance
US FAERS
34Live BirthFAERS: 55US FAERS
35MalaiseFAERS: 50US FAERS
36Drug level increasedFAERS: 47
Canada Vigilance: 2
Canada Vigilance
US FAERS
37OverdoseFAERS: 47
Canada Vigilance: 1
Canada Vigilance
US FAERS
38Product quality issueFAERS: 47US FAERS
39HypersensitivityFAERS: 44
Canada Vigilance: 1
Canada Vigilance
US FAERS
40DysmorphismFAERS: 42US FAERS
41nervous system disorderFAERS: 42US FAERS
42AstheniaFAERS: 41US FAERS
43Drug dispensing errorFAERS: 41US FAERS
44Drug level below therapeuticFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
45Toxicity to various agentsFAERS: 39US FAERS
46AmnesiaFAERS: 38US FAERS
47AgitationFAERS: 36US FAERS
48LethargyFAERS: 36
Canada Vigilance: 2
Canada Vigilance
US FAERS
49Memory impairmentFAERS: 35US FAERS
50Therapeutic response unexpected with drug substitutionFAERS: 35US FAERS
51Mental status changesFAERS: 33US FAERS
52Abdominal discomfortFAERS: 31
Canada Vigilance: 2
Canada Vigilance
US FAERS
53Drug dose omissionFAERS: 29US FAERS
54AngerFAERS: 28US FAERS
55Abdominal PainFAERS: 27
Canada Vigilance: 3
Canada Vigilance
US FAERS
56DysarthriaFAERS: 27US FAERS
57PneumoniaFAERS: 27US FAERS
58Weight decreasedFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
59Craniofacial deformityFAERS: 25US FAERS
60PruritusFAERS: 25
Canada Vigilance: 2
Canada Vigilance
US FAERS
61Suicide attemptFAERS: 25US FAERS
62DissociationFAERS: 24US FAERS
63Incorrect dose administeredFAERS: 24US FAERS
64HypospadiasFAERS: 23US FAERS
65Medication residue presentFAERS: 23US FAERS
66Mood swingsFAERS: 23US FAERS
67Supportive careFAERS: 23US FAERS
68Cerebrovascular accidentFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
69EpilepsyFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
70Bipolar DisorderFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
71White blood cell count decreasedFAERS: 21US FAERS
72DehydrationFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
73DisorientationFAERS: 19US FAERS
74Adverse eventFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
75NeutropeniaFAERS: 18
Canada Vigilance: 3
Canada Vigilance
US FAERS
76Neutrophil count decreasedFAERS: 18US FAERS
77Cleft PalateFAERS: 17US FAERS
78DeafnessFAERS: 17US FAERS
79DyspepsiaFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
80IlliteracyFAERS: 17US FAERS
81LeukopeniaFAERS: 17
Canada Vigilance: 3
Canada Vigilance
US FAERS
82Medication ErrorFAERS: 17US FAERS
83TinnitusFAERS: 17US FAERS
84Wrong technique in drug usage processFAERS: 17US FAERS
85Alanine Aminotransferase IncreasedFAERS: 16US FAERS
86Anticonvulsant drug level decreasedFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
87Aspartate Aminotransferase IncreasedFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
88Drug level fluctuatingFAERS: 16US FAERS
89NervousnessFAERS: 16US FAERS
90Visual ImpairmentFAERS: 16US FAERS
91AbasiaFAERS: 15US FAERS
92TalipesFAERS: 15US FAERS
93Anticonvulsant drug level below therapeuticFAERS: 14US FAERS
94HypersomniaFAERS: 14US FAERS
95HypophagiaFAERS: 14US FAERS
96HypotensionFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
97AtaxiaFAERS: 13US FAERS
98Blood sodium decreasedFAERS: 13US FAERS
99Completed SuicideFAERS: 13US FAERS
100CryingFAERS: 13US FAERS
101Diabetes MellitusFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
102Emotional disorderFAERS: 13US FAERS
103Product use issueFAERS: 13US FAERS
104Cerebral atrophyFAERS: 12US FAERS
105DeliriumFAERS: 12US FAERS
106Impaired self-careFAERS: 12US FAERS
107PancytopeniaFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
108ParanoiaFAERS: 12US FAERS
109Urinary tract infectionFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
110UrticariaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
111AnorexiaFAERS: 11US FAERS
112AphasiaFAERS: 11US FAERS
113Back PainFAERS: 11US FAERS
114Blood amylase increasedFAERS: 11US FAERS
115Depressed moodFAERS: 11US FAERS
116EpistaxisFAERS: 11US FAERS
117HepatotoxicityFAERS: 11US FAERS
118HydrocephalusFAERS: 11US FAERS
119Myocardial InfarctionFAERS: 11US FAERS
120Patent ductus arteriosusFAERS: 11US FAERS
121Stevens-Johnson SyndromeFAERS: 11US FAERS
122jaundiceFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
123Anticonvulsant drug level increasedFAERS: 10US FAERS
124CholelithiasisFAERS: 10US FAERS
125ConstipationFAERS: 10US FAERS
126DisabilityFAERS: 10US FAERS
127Drug prescribing errorFAERS: 10US FAERS
128DysgeusiaFAERS: 10US FAERS
129ErythemaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
130Fine motor delayFAERS: 10US FAERS
131Oppositional Defiant DisorderFAERS: 10US FAERS
132SyncopeFAERS: 10US FAERS
133Urinary IncontinenceFAERS: 10US FAERS
134ArthralgiaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
135Blood glucose increasedFAERS: 9US FAERS
136CraniosynostosisFAERS: 9US FAERS
137Depressed Level of ConsciousnessFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
138Drug level above therapeuticFAERS: 9US FAERS
139Drug toxicityFAERS: 9US FAERS
140Psychomotor skills impairedFAERS: 9US FAERS
141SepsisFAERS: 9US FAERS
142StressFAERS: 9US FAERS
143VertigoFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
144AngioedemaFAERS: 8US FAERS
145BlindnessFAERS: 8US FAERS
146Blood alkaline phosphatase increasedFAERS: 8US FAERS
147Chest PainFAERS: 8US FAERS
148Congenital neurological disorderFAERS: 8US FAERS
149FlatulenceFAERS: 8US FAERS
150Hepatic EncephalopathyFAERS: 8US FAERS
151Mental RetardationFAERS: 8US FAERS
152Product taste abnormalFAERS: 8US FAERS
153AmblyopiaFAERS: 7US FAERS
154BedriddenFAERS: 7US FAERS
155Erectile dysfunctionFAERS: 7US FAERS
156Inappropriate schedule of drug administrationFAERS: 7US FAERS
157Intelligence test abnormalFAERS: 7US FAERS
158Neuroleptic Malignant SyndromeFAERS: 7US FAERS
159OsteoporosisFAERS: 7US FAERS
160PalpitationsFAERS: 7US FAERS
161PolydactylyFAERS: 7US FAERS
162Poor quality sleepFAERS: 7US FAERS
163Respiratory arrestFAERS: 7US FAERS
164Status EpilepticusFAERS: 7US FAERS
165StomatitisFAERS: 7US FAERS
166AcidosisFAERS: 6US FAERS
167AcneFAERS: 6US FAERS
168Anticonvulsant drug level above therapeuticFAERS: 6US FAERS
169AsthmaFAERS: 6US FAERS
170AzoospermiaFAERS: 6US FAERS
171DementiaFAERS: 6US FAERS
172DiplopiaFAERS: 6US FAERS
173DysgraphiaFAERS: 6US FAERS
174Educational problemFAERS: 6US FAERS
175Hepatitis CFAERS: 6US FAERS
176HepatomegalyFAERS: 6US FAERS
177IncontinenceFAERS: 6US FAERS
178Intentional drug misuseFAERS: 6US FAERS
179Intentional self-injuryFAERS: 6US FAERS
180Joint swellingFAERS: 6US FAERS
181Lipase increasedFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
182Metabolic acidosisFAERS: 6US FAERS
183MyalgiaFAERS: 6US FAERS
184No adverse eventFAERS: 6US FAERS
185ObesityFAERS: 6US FAERS
186Product physical issueFAERS: 6US FAERS
187Respiratory DepressionFAERS: 6US FAERS
188RestlessnessFAERS: 6US FAERS
189StuporFAERS: 6US FAERS
190SwellingFAERS: 6US FAERS
191SyndactylyFAERS: 6US FAERS
192Therapeutic response changedFAERS: 6US FAERS
193Tooth LossFAERS: 6US FAERS
194Wrong drug administeredFAERS: 6US FAERS
195AscitesFAERS: 5US FAERS
196Atrial FibrillationFAERS: 5US FAERS
197Blood albumin decreasedFAERS: 5US FAERS
198Blood testosterone decreasedFAERS: 5US FAERS
199Burning sensationFAERS: 5US FAERS
200CataractFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
201ChillsFAERS: 5US FAERS
202ChokingFAERS: 5US FAERS
203Dental cariesFAERS: 5US FAERS
204DroolingFAERS: 5US FAERS
205Drug DependenceFAERS: 5US FAERS
206Drug administration errorFAERS: 5US FAERS
207Drug screen positiveFAERS: 5US FAERS
208DysphoniaFAERS: 5US FAERS
209EczemaFAERS: 5US FAERS
210Feeling jitteryFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
211Gamma-Glutamyltransferase IncreasedFAERS: 5US FAERS
212General physical health deteriorationFAERS: 5US FAERS
213HepatitisFAERS: 5US FAERS
214HypertrichosisFAERS: 5US FAERS
215InfectionFAERS: 5US FAERS
216Intercepted drug dispensing errorFAERS: 5US FAERS
217Low set earsFAERS: 5US FAERS
218MacrocephalyFAERS: 5US FAERS
219MeningomyeloceleFAERS: 5US FAERS
220Myoclonic EpilepsyFAERS: 5US FAERS
221MyoclonusFAERS: 5US FAERS
222Oropharyngeal painFAERS: 5US FAERS
223PallorFAERS: 5US FAERS
224Partner stressFAERS: 5US FAERS
225PetechiaeFAERS: 5US FAERS
226Pharmaceutical product complaintFAERS: 5US FAERS
227PhotophobiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
228PoisoningFAERS: 5US FAERS
229Pulmonary Valve StenosisFAERS: 5US FAERS
230Respiratory FailureFAERS: 5US FAERS
231Respiratory distressFAERS: 5US FAERS
232RetchingFAERS: 5US FAERS
233Skin lesionFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
234StaringFAERS: 5US FAERS
235Tardive DyskinesiaFAERS: 5US FAERS
236Therapy cessationFAERS: 5US FAERS
237treatment failureFAERS: 5US FAERS
238Altered state of consciousnessFAERS: 4US FAERS
239ArteriosclerosisFAERS: 4US FAERS
240BicytopeniaFAERS: 4US FAERS
241Bipolar I disorderFAERS: 4US FAERS
242Blood thyroid stimulating hormone increasedFAERS: 4US FAERS
243Cardiac ArrestFAERS: 4US FAERS
244CardiomegalyFAERS: 4US FAERS
245ChordeeFAERS: 4US FAERS
246Congenital HydrocephalusFAERS: 4US FAERS
247Congenital cystic kidney diseaseFAERS: 4US FAERS
248Developmental Coordination DisorderFAERS: 4US FAERS
249Disease recurrenceFAERS: 4US FAERS
250Drug ineffective for unapproved indicationFAERS: 4US FAERS
251Drug withdrawal syndromeFAERS: 4US FAERS
252Dry skinFAERS: 4US FAERS
253Electroencephalogram abnormalFAERS: 4US FAERS
254EnuresisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
255Eye painFAERS: 4US FAERS
256FibromyalgiaFAERS: 4US FAERS
257Gait inabilityFAERS: 4US FAERS
258HostilityFAERS: 4US FAERS
259Incorrect route of drug administrationFAERS: 4US FAERS
260InfluenzaFAERS: 4US FAERS
261Intellectual DisabilityFAERS: 4US FAERS
262MicrocephalyFAERS: 4US FAERS
263Musculoskeletal chest painFAERS: 4US FAERS
264Musculoskeletal stiffnessFAERS: 4US FAERS
265MydriasisFAERS: 4US FAERS
266NasopharyngitisFAERS: 4US FAERS
267Neck PainFAERS: 4US FAERS
268Obsessive-Compulsive DisorderFAERS: 4US FAERS
269Oculogyric crisisFAERS: 4US FAERS
270OverweightFAERS: 4US FAERS
271Pain of skinFAERS: 4US FAERS
272Pancreatic CystFAERS: 4US FAERS
273Pancreatic PseudocystFAERS: 4US FAERS
274Pancreatic enzymes increasedFAERS: 4US FAERS
275Personality ChangeFAERS: 4US FAERS
276Physical assaultFAERS: 4US FAERS
277PregnancyFAERS: 4US FAERS
278PriapismFAERS: 4US FAERS
279Product formulation issueFAERS: 4US FAERS
280PseudodementiaFAERS: 4US FAERS
281Sensorimotor disorderFAERS: 4US FAERS
282Sexual relationship changeFAERS: 4US FAERS
283ShockFAERS: 4US FAERS
284TachycardiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
285Throat irritationFAERS: 4US FAERS
286ThrombosisFAERS: 4US FAERS
287Transaminases increasedFAERS: 4US FAERS
288Trisomy 21FAERS: 4US FAERS
289Unresponsive to stimuliFAERS: 4US FAERS
290Vitamin B1 increasedFAERS: 4US FAERS
291Accidental exposureFAERS: 3US FAERS
292Acute kidney injuryFAERS: 3US FAERS
293Angina PectorisFAERS: 3US FAERS
294Anticonvulsant drug level abnormalFAERS: 3US FAERS
295ArthritisFAERS: 3US FAERS
296Blighted ovumFAERS: 3US FAERS
297Bone painFAERS: 3US FAERS
298BradycardiaFAERS: 3US FAERS
299BradykinesiaFAERS: 3US FAERS
300Breast tendernessFAERS: 3US FAERS
301CatatoniaFAERS: 3US FAERS
302Chest discomfortFAERS: 3US FAERS
303ChromaturiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
304Congenital tracheomalaciaFAERS: 3US FAERS
305CyanosisFAERS: 3US FAERS
306Dandy-Walker SyndromeFAERS: 3US FAERS
307Device occlusionFAERS: 3US FAERS
308DiscomfortFAERS: 3US FAERS
309DrowningFAERS: 3US FAERS
310Drug administered to patient of inappropriate ageFAERS: 3US FAERS
311Drug effect incompleteFAERS: 3US FAERS
312Drug level changedFAERS: 3US FAERS
313DystoniaFAERS: 3US FAERS
314Ear discomfortFAERS: 3US FAERS
315Ectopic PregnancyFAERS: 3US FAERS
316EncephalitisFAERS: 3US FAERS
317EosinophiliaFAERS: 3US FAERS
318Executive dysfunctionFAERS: 3US FAERS
319Exposure via ingestionFAERS: 3US FAERS
320Facial PainFAERS: 3US FAERS
321Failure to ThriveFAERS: 3US FAERS
322Fanconi SyndromeFAERS: 3US FAERS
323Feeling ColdFAERS: 3US FAERS
324Finger hypoplasiaFAERS: 3US FAERS
325FlushingFAERS: 3US FAERS
326Gastric BypassFAERS: 3US FAERS
327GastritisFAERS: 3US FAERS
328Gaze palsyFAERS: 3US FAERS
329GliosisFAERS: 3US FAERS
330Grip strength decreasedFAERS: 3US FAERS
331Growth retardationFAERS: 3US FAERS
332HirsutismFAERS: 3US FAERS
333Hormone level abnormalFAERS: 3US FAERS
334HungerFAERS: 3US FAERS
335HydronephrosisFAERS: 3US FAERS
336HyperchlorhydriaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
337Hypothalamo-pituitary disorderFAERS: 3US FAERS
338HypothyroidismFAERS: 3US FAERS
339HypoxiaFAERS: 3US FAERS
340IleusFAERS: 3US FAERS
341Impaired driving abilityFAERS: 3US FAERS
342Inappropriate schedule of product administrationFAERS: 3US FAERS
343IncoherentFAERS: 3US FAERS
344Incorrect drug administration durationFAERS: 3US FAERS
345Irritable Bowel SyndromeFAERS: 3US FAERS
346Limb injuryFAERS: 3US FAERS
347LymphadenopathyFAERS: 3US FAERS
348MacrocytosisFAERS: 3US FAERS
349Mastication disorderFAERS: 3US FAERS
350Middle insomniaFAERS: 3US FAERS
351Mitochondrial cytopathyFAERS: 3US FAERS
352Muscle RigidityFAERS: 3US FAERS
353MyoglobinuriaFAERS: 3US FAERS
354Paradoxical drug reactionFAERS: 3US FAERS
355Pectus excavatumFAERS: 3US FAERS
356PericarditisFAERS: 3US FAERS
357PneumothoraxFAERS: 3US FAERS
358Precocious PubertyFAERS: 3US FAERS
359Product packaging issueFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
360Rash erythematousFAERS: 3US FAERS
361Renal painFAERS: 3US FAERS
362RhabdomyolysisFAERS: 3US FAERS
363Sexual DysfunctionFAERS: 3US FAERS
364SinusitisFAERS: 3US FAERS
365SluggishnessFAERS: 3US FAERS
366SynostosisFAERS: 3US FAERS
367TachyphreniaFAERS: 3US FAERS
368Tension HeadacheFAERS: 3US FAERS
369ThirstFAERS: 3US FAERS
370Tongue bitingFAERS: 3US FAERS
371Tooth ErosionFAERS: 3US FAERS
372TorticollisFAERS: 3US FAERS
373Toxic Epidermal NecrolysisFAERS: 3US FAERS
374TracheomalaciaFAERS: 3US FAERS
375TrichorrhexisFAERS: 3US FAERS
376Violence-related symptomFAERS: 3US FAERS
377Vision abnormal neonatalFAERS: 3US FAERS
378Wheelchair userFAERS: 3US FAERS
379AbuliaFAERS: 2US FAERS
380Accidental drug intake by childFAERS: 2US FAERS
381Accidental overdoseFAERS: 2US FAERS
382Ammonia abnormalFAERS: 2US FAERS
383Amylase increasedFAERS: 2US FAERS
384Ankle FractureFAERS: 2US FAERS
385Antipsychotic drug level below therapeuticFAERS: 2US FAERS
386ApathyFAERS: 2US FAERS
387AphagiaFAERS: 2US FAERS
388ArthropathyFAERS: 2US FAERS
389AsterixisFAERS: 2US FAERS
390AstigmatismFAERS: 2US FAERS
391Atrioventricular BlockFAERS: 2US FAERS
392AuraFAERS: 2US FAERS
393BlepharospasmFAERS: 2US FAERS
394Blood count abnormalFAERS: 2US FAERS
395Blood folate decreasedFAERS: 2US FAERS
396Blood glucose abnormalFAERS: 2US FAERS
397Blood gonadotrophin decreasedFAERS: 2US FAERS
398Blood iron decreasedFAERS: 2US FAERS
399Blood pressure fluctuationFAERS: 2US FAERS
400Blood sodium increasedFAERS: 2US FAERS
401Blood thyroid stimulating hormone decreasedFAERS: 2US FAERS
402Blood triglycerides increasedFAERS: 2US FAERS
403Blood urea increasedFAERS: 2US FAERS
404BrachycephalyFAERS: 2US FAERS
405BradyphreniaFAERS: 2US FAERS
406BruxismFAERS: 2US FAERS
407Carnitine decreasedFAERS: 2US FAERS
408Carnitine deficiencyFAERS: 2US FAERS
409Cerebral ThrombosisFAERS: 2US FAERS
410Cerebral ventricle dilatationFAERS: 2US FAERS
411Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
412Complex partial seizuresFAERS: 2US FAERS
413Congenital HypothyroidismFAERS: 2US FAERS
414ConjunctivitisFAERS: 2US FAERS
415Consciousness fluctuatingFAERS: 2US FAERS
416Dacryostenosis congenitalFAERS: 2US FAERS
417DemyelinationFAERS: 2US FAERS
418Diabetes InsipidusFAERS: 2US FAERS
419DiverticulitisFAERS: 2US FAERS
420Drug screen false positiveFAERS: 2US FAERS
421DysuriaFAERS: 2US FAERS
422Emergency CareFAERS: 2US FAERS
423EructationFAERS: 2US FAERS
424Expired product administeredFAERS: 2US FAERS
425Febrile NeutropeniaFAERS: 2US FAERS
426Flight of ideasFAERS: 2US FAERS
427FrustrationFAERS: 2US FAERS
428GastrectomyFAERS: 2US FAERS
429Gastrointestinal PainFAERS: 2US FAERS
430Gastrointestinal hypermotilityFAERS: 2US FAERS
431Gastrointestinal infectionFAERS: 2US FAERS
432Gastrointestinal inflammationFAERS: 2US FAERS
433Gastrointestinal sounds abnormalFAERS: 2US FAERS
434GastroschisisFAERS: 2US FAERS
435GastrostomyFAERS: 2US FAERS
436Gingival HyperplasiaFAERS: 2US FAERS
437GingivitisFAERS: 2US FAERS
438Head deformityFAERS: 2US FAERS
439Head titubationFAERS: 2US FAERS
440HemiparesisFAERS: 2US FAERS
441Hooded prepuceFAERS: 2US FAERS
442HyperacusisFAERS: 2US FAERS
443HyperphagiaFAERS: 2US FAERS
444HypomaniaFAERS: 2US FAERS
445Impaired gastric emptyingFAERS: 2US FAERS
446Impaired reasoningFAERS: 2US FAERS
447Increased tendency to bruiseFAERS: 2US FAERS
448InflammationFAERS: 2US FAERS
449Initial insomniaFAERS: 2US FAERS
450Intervertebral disc disorderFAERS: 2US FAERS
451Joint injuryFAERS: 2US FAERS
452LaryngomalaciaFAERS: 2US FAERS
453Ligament ruptureFAERS: 2US FAERS
454Lip swellingFAERS: 2US FAERS
455MalabsorptionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
456MenorrhagiaFAERS: 2US FAERS
457MetamorphopsiaFAERS: 2US FAERS
458MicrophthalmosFAERS: 2US FAERS
459Mild Mental RetardationFAERS: 2US FAERS
460Mineral deficiencyFAERS: 2US FAERS
461Muscle tightnessFAERS: 2US FAERS
462Musculoskeletal PainFAERS: 2US FAERS
463MyopiaFAERS: 2US FAERS
464Neutrophil count abnormalFAERS: 2US FAERS
465Night sweatsFAERS: 2US FAERS
466NocturiaFAERS: 2US FAERS
467ObstructionFAERS: 2US FAERS
468Ocular icterusFAERS: 2US FAERS
469OligospermiaFAERS: 2US FAERS
470Optic NeuritisFAERS: 2US FAERS
471OsteopeniaFAERS: 2US FAERS
472Oxygen saturation abnormalFAERS: 2US FAERS
473PancreatectomyFAERS: 2US FAERS
474Pancreatic carcinomaFAERS: 2US FAERS
475Penile curvatureFAERS: 2US FAERS
476Pericardial effusionFAERS: 2US FAERS
477Peripheral swellingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
478PolydipsiaFAERS: 2US FAERS
479PolyuriaFAERS: 2US FAERS
480Poor quality drug administeredFAERS: 2US FAERS
481PresyncopeFAERS: 2US FAERS
482Product blister packaging issueFAERS: 2US FAERS
483Product counterfeitFAERS: 2US FAERS
484Product storage errorFAERS: 2US FAERS
485PseudocystFAERS: 2US FAERS
486Pulmonary HypertensionFAERS: 2US FAERS
487SchizophreniaFAERS: 2US FAERS
488Sensory integrative dysfunctionFAERS: 2US FAERS
489Sensory level abnormalFAERS: 2US FAERS
490Single umbilical arteryFAERS: 2US FAERS
491Sinus headacheFAERS: 2US FAERS
492SnoringFAERS: 2US FAERS
493StrabismusFAERS: 2US FAERS
494SyringomyeliaFAERS: 2US FAERS
495TachyarrhythmiaFAERS: 2US FAERS
496Therapeutic response unexpectedFAERS: 2US FAERS
497Therapy changeFAERS: 2US FAERS
498ToothacheFAERS: 2US FAERS
499TrichotillomaniaFAERS: 2US FAERS
500Tricuspid Valve StenosisFAERS: 2US FAERS
501TrismusFAERS: 2US FAERS
502UlcerFAERS: 2US FAERS
503Vagus Nerve DisorderFAERS: 2US FAERS
504Vitamin D DeficiencyFAERS: 2US FAERS
505Walking aid userFAERS: 2US FAERS
506Wrong technique in product usage processFAERS: 2US FAERS
507ACTH stimulation test abnormalFAERS: 1US FAERS
508Abdominal tendernessFAERS: 1US FAERS
509Abnormal palmar/plantar creasesFAERS: 1US FAERS
510Abnormal weight gainFAERS: 1US FAERS
511Acquired von Willebrand's diseaseFAERS: 1US FAERS
512AgranulocytosisFAERS: 1US FAERS
513AkinesiaFAERS: 1US FAERS
514Alcohol abuseFAERS: 1US FAERS
515Alcohol interactionFAERS: 1US FAERS
516Alcohol poisoningFAERS: 1US FAERS
517Allergic reaction to excipientFAERS: 1US FAERS
518Allergic respiratory symptomFAERS: 1US FAERS
519Alopecia AreataFAERS: 1US FAERS
520Altered visual depth perceptionFAERS: 1US FAERS
521Ammonia decreasedFAERS: 1US FAERS
522Anaphylactic shockFAERS: 1US FAERS
523AnencephalyFAERS: 1US FAERS
524AneurysmFAERS: 1US FAERS
525AnorgasmiaFAERS: 1US FAERS
526Antipsychotic drug level above therapeuticFAERS: 1US FAERS
527Antipsychotic drug level increasedFAERS: 1US FAERS
528Antithrombin III DeficiencyFAERS: 1US FAERS
529AnuriaFAERS: 1US FAERS
530AphoniaFAERS: 1US FAERS
531AppendicitisFAERS: 1US FAERS
532ArachnodactylyFAERS: 1US FAERS
533Arthropod biteFAERS: 1US FAERS
534Aspartate aminotransferase abnormalFAERS: 1US FAERS
535AsphyxiaFAERS: 1US FAERS
536AsthenopiaFAERS: 1US FAERS
537AtelectasisFAERS: 1US FAERS
538AthetosisFAERS: 1US FAERS
539Bacterial sepsisFAERS: 1US FAERS
540Bariatric gastric balloon insertionFAERS: 1US FAERS
541BelligerenceFAERS: 1US FAERS
542Bicuspid aortic valveFAERS: 1US FAERS
543Blood alcohol increasedFAERS: 1US FAERS
544Blood chloride decreasedFAERS: 1US FAERS
545Blood creatine increasedFAERS: 1US FAERS
546Blood creatine phosphokinase increasedFAERS: 1US FAERS
547Blood creatinine increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
548Blood glucose decreasedFAERS: 1US FAERS
549Blood homocysteine increasedFAERS: 1US FAERS
550Blood immunoglobulin A decreasedFAERS: 1US FAERS
551Blood iron increasedFAERS: 1US FAERS
552Blood lactate dehydrogenase increasedFAERS: 1US FAERS
553Blood magnesium decreasedFAERS: 1US FAERS
554Blood parathyroid hormone increasedFAERS: 1US FAERS
555Blood potassium increasedFAERS: 1US FAERS
556Blood prolactin increasedFAERS: 1US FAERS
557Blood testosterone increasedFAERS: 1US FAERS
558Blood urea nitrogen/creatinine ratio increasedFAERS: 1US FAERS
559Blood urine presentFAERS: 1US FAERS
560Bone density decreasedFAERS: 1US FAERS
561BrachydactylyFAERS: 1US FAERS
562Brain DeathFAERS: 1US FAERS
563Breath alcohol test positiveFAERS: 1US FAERS
564BronchitisFAERS: 1US FAERS
565Bronchopulmonary DysplasiaFAERS: 1US FAERS
566CalcinosisFAERS: 1US FAERS
567Capsule physical issueFAERS: 1US FAERS
568Cardiac FlutterFAERS: 1US FAERS
569Carotid artery occlusionFAERS: 1US FAERS
570Catheter sepsisFAERS: 1US FAERS
571Cell DeathFAERS: 1US FAERS
572CellulitisFAERS: 1US FAERS
573Cerebellar AtaxiaFAERS: 1US FAERS
574Cerebral InfarctionFAERS: 1US FAERS
575Cerebral disorderFAERS: 1US FAERS
576Change in sustained attentionFAERS: 1US FAERS
577CheilitisFAERS: 1US FAERS
578CholangitisFAERS: 1US FAERS
579CholestasisFAERS: 1US FAERS
580ChoreaFAERS: 1US FAERS
581ClaustrophobiaFAERS: 1US FAERS
582Coagulation factor VIII level decreasedFAERS: 1US FAERS
583ColitisFAERS: 1US FAERS
584Coma scale abnormalFAERS: 1US FAERS
585Complement factor C4 decreasedFAERS: 1US FAERS
586Complication associated with deviceFAERS: 1US FAERS
587Congenital brain damageFAERS: 1US FAERS
588Congenital choroid plexus cystFAERS: 1US FAERS
589Congenital cutis laxaFAERS: 1US FAERS
590Congenital hearing disorderFAERS: 1US FAERS
591Congenital pulmonary hypertensionFAERS: 1US FAERS
592Congenital renal cystFAERS: 1US FAERS
593Congenital renal disorderFAERS: 1US FAERS
594Congenital scoliosisFAERS: 1US FAERS
595Convulsion in childhoodFAERS: 1US FAERS
596Cortisol free urine increasedFAERS: 1US FAERS
597CystFAERS: 1US FAERS
598Cytolytic hepatitisFAERS: 1US FAERS
599Deafness NeurosensoryFAERS: 1US FAERS
600Decreased eye contactFAERS: 1US FAERS
601Deep Vein ThrombosisFAERS: 1US FAERS
602Dehydroepiandrosterone decreasedFAERS: 1US FAERS
603Dehydroepiandrosterone increasedFAERS: 1US FAERS
604Delayed PubertyFAERS: 1US FAERS
605Delusional disorder, unspecified typeFAERS: 1US FAERS
606Depression suicidalFAERS: 1US FAERS
607DermatitisFAERS: 1US FAERS
608Diabetes mellitus inadequate controlFAERS: 1US FAERS
609Diabetic KetoacidosisFAERS: 1US FAERS
610Diet refusalFAERS: 1US FAERS
611Disability assessment scale score decreasedFAERS: 1US FAERS
612Disease complicationFAERS: 1US FAERS
613Dreamy stateFAERS: 1US FAERS
614Drug ToleranceFAERS: 1US FAERS
615Drug abuseFAERS: 1US FAERS
616Drug exposure via breast milkFAERS: 1US FAERS
617Drug label confusionFAERS: 1US FAERS
618Dust inhalation pneumopathyFAERS: 1US FAERS
619DyscheziaFAERS: 1US FAERS
620DyslexiaFAERS: 1US FAERS
621DysphemiaFAERS: 1US FAERS
622Ear tube insertionFAERS: 1US FAERS
623Ectopic kidneyFAERS: 1US FAERS
624Electrocardiogram T wave peakedFAERS: 1US FAERS
625Electrocardiogram changeFAERS: 1US FAERS
626Electrocardiogram repolarisation abnormalityFAERS: 1US FAERS
627Embolic strokeFAERS: 1US FAERS
628Enzyme abnormalityFAERS: 1US FAERS
629Eosinophilic cystitisFAERS: 1US FAERS
630Epidermal necrosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
631Epilepsy congenitalFAERS: 1US FAERS
632Erythema MultiformeFAERS: 1US FAERS
633Essential HypertensionFAERS: 1US FAERS
634Excessive eye blinkingFAERS: 1US FAERS
635Expired drug administeredFAERS: 1US FAERS
636Exposure during breast feedingFAERS: 1US FAERS
637Extremity contractureFAERS: 1US FAERS
638Eye irritationFAERS: 1US FAERS
639Feeding disorder neonatalFAERS: 1US FAERS
640Feelings of worthlessnessFAERS: 1US FAERS
641Flat affectFAERS: 1US FAERS
642Focal dyscognitive seizuresFAERS: 1US FAERS
643Food aversionFAERS: 1US FAERS
644Foreign body in respiratory tractFAERS: 1US FAERS
645FormicationFAERS: 1US FAERS
646FractureFAERS: 1US FAERS
647Frontotemporal dementiaFAERS: 1US FAERS
648FrostbiteFAERS: 1US FAERS
649Frustration tolerance decreasedFAERS: 1US FAERS
650Full blood count abnormalFAERS: 1US FAERS
651Gallbladder anomaly congenitalFAERS: 1US FAERS
652Gastric DilatationFAERS: 1US FAERS
653GastroenteritisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
654Gastrointestinal mucosal disorderFAERS: 1US FAERS
655Gastrooesophageal sphincter insufficiencyFAERS: 1US FAERS
656General physical conditionFAERS: 1US FAERS
657General physical condition abnormalFAERS: 1US FAERS
658General symptomFAERS: 1US FAERS
659Gingival HypertrophyFAERS: 1US FAERS
660Gingival RecessionFAERS: 1US FAERS
661GlaucomaFAERS: 1US FAERS
662GoutFAERS: 1US FAERS
663Granulocyte count decreasedFAERS: 1US FAERS
664HaematotoxicityFAERS: 1US FAERS
665Head circumference abnormalFAERS: 1US FAERS
666Head discomfortFAERS: 1US FAERS
667Heart sounds abnormalFAERS: 1US FAERS
668Heat StrokeFAERS: 1US FAERS
669Hepatic enzyme decreasedFAERS: 1US FAERS
670Hepatitis AFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
671Hepatitis B core antigen positiveFAERS: 1US FAERS
672Hepatitis C antibody positiveFAERS: 1US FAERS
673HerniaFAERS: 1US FAERS
674Human papilloma virus test positiveFAERS: 1US FAERS
675HypercapniaFAERS: 1US FAERS
676HypermetabolismFAERS: 1US FAERS
677Hypertensive crisisFAERS: 1US FAERS
678Hypertensive heart diseaseFAERS: 1US FAERS
679HyperventilationFAERS: 1US FAERS
680HypokinesiaFAERS: 1US FAERS
681HypometabolismFAERS: 1US FAERS
682HypopituitarismFAERS: 1US FAERS
683Hypoplastic Left Heart SyndromeFAERS: 1US FAERS
684Incorrect dose administered by deviceFAERS: 1US FAERS
685Incorrect drug dosage form administeredFAERS: 1US FAERS
686Incorrect product formulation administeredFAERS: 1US FAERS
687Incorrect storage of drugFAERS: 1US FAERS
688Infantile apnoeic attackFAERS: 1US FAERS
689InfarctionFAERS: 1US FAERS
690Insulin ResistanceFAERS: 1US FAERS
691Intentional misuseFAERS: 1US FAERS
692Intentional product misuseFAERS: 1US FAERS
693Intestinal ObstructionFAERS: 1US FAERS
694Intestinal cystFAERS: 1US FAERS
695Intracranial HypotensionFAERS: 1US FAERS
696Joint InstabilityFAERS: 1US FAERS
697Joint laxityFAERS: 1US FAERS
698Joint sprainFAERS: 1US FAERS
699LacerationFAERS: 1US FAERS
700Lack of spontaneous speechFAERS: 1US FAERS
701Leukocytoclastic vasculitisFAERS: 1US FAERS
702Lipase abnormalFAERS: 1US FAERS
703LipomaFAERS: 1US FAERS
704Lobar PneumoniaFAERS: 1US FAERS
705Loose associationsFAERS: 1US FAERS
706Lupus-like syndromeFAERS: 1US FAERS
707Lymphocyte count decreasedFAERS: 1US FAERS
708LymphocytosisFAERS: 1US FAERS
709LymphomaFAERS: 1US FAERS
710MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
711Macular degenerationFAERS: 1US FAERS
712Malabsorption from administration siteFAERS: 1US FAERS
713MalnutritionFAERS: 1US FAERS
714MalocclusionFAERS: 1US FAERS
715Medication monitoring errorFAERS: 1US FAERS
716MeningitisFAERS: 1US FAERS
717Mental retardation severity unspecifiedFAERS: 1US FAERS
718MetrorrhagiaFAERS: 1US FAERS
719MicrostomiaFAERS: 1US FAERS
720Migraine with AuraFAERS: 1US FAERS
721Mixed liver injuryFAERS: 1US FAERS
722MoaningFAERS: 1US FAERS
723MonoplegiaFAERS: 1US FAERS
724Musculoskeletal discomfortFAERS: 1US FAERS
725Myasthenia GravisFAERS: 1US FAERS
726MyositisFAERS: 1US FAERS
727NarcolepsyFAERS: 1US FAERS
728NecrosisFAERS: 1US FAERS
729Negative thoughtsFAERS: 1US FAERS
730NegativismFAERS: 1US FAERS
731Neonatal cardiac failureFAERS: 1US FAERS
732Neonatal disorderFAERS: 1US FAERS
733Neonatal respiratory arrestFAERS: 1US FAERS
734Nephrogenic Diabetes InsipidusFAERS: 1US FAERS
735NephrolithiasisFAERS: 1US FAERS
736Nerve injuryFAERS: 1US FAERS
737NeuralgiaFAERS: 1US FAERS
738NeuritisFAERS: 1US FAERS
739NeurodermatitisFAERS: 1US FAERS
740Neurogenic BowelFAERS: 1US FAERS
741Neurological decompensationFAERS: 1US FAERS
742NeuromaFAERS: 1US FAERS
743Neutrophil Pelger-Huet anomaly presentFAERS: 1US FAERS
744Nipple painFAERS: 1US FAERS
745NoduleFAERS: 1US FAERS
746Non-cardiac chest painFAERS: 1US FAERS
747NystagmusFAERS: 1US FAERS
748OligohydramniosFAERS: 1US FAERS
749OnychoclasisFAERS: 1US FAERS
750OnycholysisFAERS: 1US FAERS
751Opiates positiveFAERS: 1US FAERS
752Optic Nerve HypoplasiaFAERS: 1US FAERS
753Optic NeuropathyFAERS: 1US FAERS
754Oral infectionFAERS: 1US FAERS
755Oral painFAERS: 1US FAERS
756Orgasmic sensation decreasedFAERS: 1US FAERS
757Oromandibular dystoniaFAERS: 1US FAERS
758Oropharyngeal swellingFAERS: 1US FAERS
759Orthostatic hypertensionFAERS: 1US FAERS
760OsteomalaciaFAERS: 1US FAERS
761Otitis MediaFAERS: 1US FAERS
762Pancreatic Duct StenosisFAERS: 1US FAERS
763Pancreatic duct obstructionFAERS: 1US FAERS
764ParesisFAERS: 1US FAERS
765Patient dissatisfaction with treatmentFAERS: 1US FAERS
766Pelvic kidneyFAERS: 1US FAERS
767Penile size reducedFAERS: 1US FAERS
768Performance status decreasedFAERS: 1US FAERS
769Peripheral venous diseaseFAERS: 1US FAERS
770Peritoneal DialysisFAERS: 1US FAERS
771PeritonitisFAERS: 1US FAERS
772Pharyngeal erosionFAERS: 1US FAERS
773PhimosisFAERS: 1US FAERS
774Physical abuseFAERS: 1US FAERS
775PlagiocephalyFAERS: 1US FAERS
776PlasmapheresisFAERS: 1US FAERS
777PleurisyFAERS: 1US FAERS
778PolymicrogyriaFAERS: 1US FAERS
779Poor dental conditionFAERS: 1US FAERS
780Poor quality product administeredFAERS: 1US FAERS
781Poor weight gain neonatalFAERS: 1US FAERS
782Portal Vein ThrombosisFAERS: 1US FAERS
783Positron emission tomogram abnormalFAERS: 1US FAERS
784Post procedural complicationFAERS: 1US FAERS
785Post-Traumatic Stress DisorderFAERS: 1US FAERS
786Postoperative thrombosisFAERS: 1US FAERS
787Pre-EclampsiaFAERS: 1US FAERS
788Prealbumin increasedFAERS: 1US FAERS
789Prescribed underdoseFAERS: 1US FAERS
790Product availability issueFAERS: 1US FAERS
791Product coating issueFAERS: 1US FAERS
792Product complaintFAERS: 1US FAERS
793Product contaminationFAERS: 1US FAERS
794Product difficult to swallowFAERS: 1US FAERS
795Product dispensing errorFAERS: 1US FAERS
796Product dose omissionFAERS: 1US FAERS
797Product expiration date issueFAERS: 1US FAERS
798Product label issueFAERS: 1US FAERS
799Product lot number issueFAERS: 1US FAERS
800Product packaging quantity issueFAERS: 1US FAERS
801Product prescribing errorFAERS: 1US FAERS
802Product residue presentFAERS: 1US FAERS
803Product size issueFAERS: 1US FAERS
804Product solubility abnormalFAERS: 1US FAERS
805Product supply issueFAERS: 1US FAERS
806Product tamperingFAERS: 1US FAERS
807Product use complaintFAERS: 1US FAERS
808Product use in unapproved indicationFAERS: 1US FAERS
809Progesterone increasedFAERS: 1US FAERS
810Protein total increasedFAERS: 1US FAERS
811PseudolymphomaFAERS: 1US FAERS
812Pulmonary EmbolismFAERS: 1US FAERS
813Pulmonary malformationFAERS: 1US FAERS
814QuadriplegiaFAERS: 1US FAERS
815Radial nerve palsyFAERS: 1US FAERS
816Reaction to azo-dyesFAERS: 1US FAERS
817Reaction to drug excipientsFAERS: 1US FAERS
818Rebound effectFAERS: 1US FAERS
819Rectal tenesmusFAERS: 1US FAERS
820Reflux laryngitisFAERS: 1US FAERS
821RegurgitationFAERS: 1US FAERS
822Renal cystFAERS: 1US FAERS
823Renal dysplasiaFAERS: 1US FAERS
824Renal fusion anomalyFAERS: 1US FAERS
825Renal malpositionFAERS: 1US FAERS
826Renal tubular disorderFAERS: 1US FAERS
827Restless Legs SyndromeFAERS: 1US FAERS
828Retinal Artery OcclusionFAERS: 1US FAERS
829Retinal DetachmentFAERS: 1US FAERS
830Retinal scarFAERS: 1US FAERS
831RhinitisFAERS: 1US FAERS
832Right Ventricular HypertrophyFAERS: 1US FAERS
833Schizoaffective DisorderFAERS: 1US FAERS
834Schizotypal Personality DisorderFAERS: 1US FAERS
835School refusalFAERS: 1US FAERS
836ScreamingFAERS: 1US FAERS
837Selective MutismFAERS: 1US FAERS
838Septic ShockFAERS: 1US FAERS
839Septo-Optic DysplasiaFAERS: 1US FAERS
840Sick relativeFAERS: 1US FAERS
841Simple Partial SeizuresFAERS: 1US FAERS
842Sjogren's SyndromeFAERS: 1US FAERS
843Skin UlcerFAERS: 1US FAERS
844Skin irritationFAERS: 1US FAERS
845Skin lacerationFAERS: 1US FAERS
846Skin reactionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
847Sperm count decreasedFAERS: 1US FAERS
848Spinal column stenosisFAERS: 1US FAERS
849Spontaneous penile erectionFAERS: 1US FAERS
850StillbirthFAERS: 1US FAERS
851Sudden Cardiac DeathFAERS: 1US FAERS
852Sudden deathFAERS: 1US FAERS
853Suspected counterfeit productFAERS: 1US FAERS
854Systemic lupus erythematosus rashFAERS: 1US FAERS
855Tablet issueFAERS: 1US FAERS
856Temporal ArteritisFAERS: 1US FAERS
857Terminal stateFAERS: 1US FAERS
858Therapy non-responderFAERS: 1US FAERS
859Thermal burnFAERS: 1US FAERS
860Thought withdrawalFAERS: 1US FAERS
861Throat cancerFAERS: 1US FAERS
862ThymomaFAERS: 1US FAERS
863Tobacco userFAERS: 1US FAERS
864Tongue exfoliationFAERS: 1US FAERS
865TonsillectomyFAERS: 1US FAERS
866Tooth delaminationFAERS: 1US FAERS
867Traumatic Brain InjuryFAERS: 1US FAERS
868Trigeminal NeuralgiaFAERS: 1US FAERS
869Tuberculin TestFAERS: 1US FAERS
870Ultrasound scan abnormalFAERS: 1US FAERS
871Upper airway obstructionFAERS: 1US FAERS
872Urinary RetentionFAERS: 1US FAERS
873Urine homocystine presentFAERS: 1US FAERS
874Urine osmolarity increasedFAERS: 1US FAERS
875UrinomaFAERS: 1US FAERS
876VasculitisFAERS: 1US FAERS
877Ventricular FibrillationFAERS: 1US FAERS
878Ventricular hypertrophyFAERS: 1US FAERS
879Victim of homicideFAERS: 1US FAERS
880Vitreous floatersFAERS: 1US FAERS
881Vocal Cord ParalysisFAERS: 1US FAERS
882White blood cell count normalFAERS: 1US FAERS
883Wrist deformityFAERS: 1US FAERS
884Wrong patient received medicationFAERS: 1US FAERS
885ovarian neoplasmFAERS: 1US FAERS
886skin abrasionFAERS: 1US FAERS
887Blood fibrinogen decreasedCanada Vigilance: 1Canada Vigilance
888ErythropeniaCanada Vigilance: 1Canada Vigilance
889Muscle SpasticityCanada Vigilance: 1Canada Vigilance
890Psychiatric symptomCanada Vigilance: 1Canada Vigilance
891SplenomegalyCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.